Artelo Biosciences - Investor Summit Group

Artelo Biosciences

Ticker

ARTL

Website

Sector

Healthcare

Tearsheet

Why Invest

Clinical stage biopharmaceutical company developing a portfolio of therapeutic lipid-modification candidates focused on significant unmet needs in the treatment of cancer and other serious diseases. Clinical milestones from CAReS expected for lead program throughout 2022. Well-capitalized to achieve clinical milestones and value inflection events. Comprehensive issued (6) and pending (16) patents includes owned, licensed, and partnered.